Stay updated on Extension Study of Upadacitinib in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Extension Study of Upadacitinib in Atopic Dermatitis Clinical Trial page.

Latest updates to the Extension Study of Upadacitinib in Atopic Dermatitis Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedAdded Revision: v3.4.2 and removed Revision: v3.4.1, reflecting a minor site version update.SummaryDifference0.0%

- Check19 days agoChange DetectedRevision: v3.4.1 was added and Revision: v3.4.0 was removed.SummaryDifference0.0%

- Check41 days agoChange DetectedMinor revision update observed: the page shows Revision: v3.3.4 (replacing v3.3.3), with no changes to study content, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check62 days agoChange DetectedThe Locations section adds numerous new sites across the US, Canada, Europe, Australia, and other regions, and removes many previously listed sites. This expands and reduces where participants can enroll in the study.SummaryDifference3%

- Check91 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.2.0 was removed from the page.SummaryDifference0.3%

- Check99 days agoChange DetectedNotice about government funding and operating status has been removed. The removal does not affect the study details, eligibility criteria, or results.SummaryDifference0.2%

Stay in the know with updates to Extension Study of Upadacitinib in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Extension Study of Upadacitinib in Atopic Dermatitis Clinical Trial page.